CLINICAL_TRIALS
trial_result
· 2010-08-04
Clinical Trial Update: A Study of Tocilizumab in Combination With DMARDs in Patients With Moderate to Severe Rheumatoid Arthritis [Phase 3]
Summary
Phase 3 trial evaluating tocilizumab in combination with DMARDs for moderate to severe rheumatoid arthritis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2010-08-04